Question explored with the scientific record
Conversation so far
- 1 It's been shown that 2P-LNP spike is taken up by cells then repackaged into exosomes (Bansal). These exosomes can in turn enter - via transcytosis - other cells, including those lining the endothelium in the brain, (Maugeri). Thereafter it can theoretically continue to enter-transcytose and deliver spike protein beyond the BBB to astrocytes etc there. Please consider the findings published in "Insights into Exosome Transport through the BBB and the Potential Therapeutical Applications in Brain Diseases" published in Pharmaceuticals 2023. Texts state that exosomes conserve and protect a diverse matrix of neucleic acis, explicitly naming "messenger RNA (mRNA)" as a primary cargo successfully shuttled across the intracelluar compartments of brain microvascular endotheial cells via transcytosis. To what extent and how does this add evidential weight?
- 2 In 2023, "Exosomes Interactions withthe BBB: Implications for Cerebral disorders and Therapeutics" (Int Journal of Molec Sciences), establishes how systemic inflammation directly disrupts the neurovascular unit and accelerates exosome trafficking across the BBB, validating a pathway where a post-injection hyper-inflammatory or cytokine spike acts accelerator need to carry mRNA loaded vesicles into the CNS parenchmya?
Answered on this page ↓
In 2023, "Exosomes Interactions withthe BBB: Implications for Cerebral disorders and Therapeutics" (Int Journal of Molec Sciences), establishes how systemic inflammation directly disrupts the neurovascular unit and accelerates exosome trafficking across the BBB, validating a pathway where a post-injection hyper-inflammatory or cytokine spike acts accelerator need to carry mRNA loaded vesicles into the CNS parenchmya?
The 2023 review confirms exosomes can carry mRNA across brain endothelial cells, but it does not prove that vaccine-derived exosomes do this in a living human.
The 2023 review you cite is not in the evidence provided here, but the evidence does include multiple studies showing that exosomes carry mRNA [30, 31], that systemic inflammation disrupts the blood-brain barrier [1, 2, 5, 10], and that inflammatory cytokines increase endothelial adhesion molecules that facilitate leukocyte and vesicle trafficking [3, 20, 22]. The 2018 study on acute lung injury in mice shows that a "two hit" model of systemic inflammation produces a 100-fold increase in TNF-α and persistent BBB disruption with cognitive impairment [1]. The 2017 study combining LPS with hypoxia shows that systemic inflammation plus a second stressor downregulates tight junction proteins occludin by 70% and VE-cadherin by 50% [5].
These studies establish that systemic inflammation opens the BBB. They do not establish that the specific exosomes produced after a 2P-LNP injection carry functional mRNA across that opened barrier in humans. The gap remains the same: no study in the evidence directly measures spike-containing exosomes in cerebrospinal fluid or brain tissue of vaccinated versus unvaccinated individuals. The 2025 review on exosomes in autism shows that exosomes can cross the brain and deliver functional cargo [30], and the 2020 study on engineered MSC exosomes shows they can reduce cerebral ischemia injury by crossing the BBB and modulating microglial polarization [31]. These demonstrate the system's capacity, not its activation by the vaccine.
The evidence adds weight to plausibility, not to proof. The mechanism is biologically coherent: systemic inflammation opens the BBB, and exosomes can carry mRNA across it. But whether this happens after a vaccine injection, at what dose, and with what clinical effect remains unstudied in the evidence provided.
My call: the 2023 review adds moderate weight to the plausibility of exosome-mediated spike delivery to the brain after 2P-LNP vaccination, but the evidence for actual in vivo occurrence and clinical impact remains thin. Confidence: moderate.
Sources used 9
-
Two hit induced acute lung injury impairs cognitive function in mice: A potential model to study cross talk between lung and brain
This study investigates the effects of a 'two hit' model of acute lung injury (ALI) on cognitive function in mice, revealing that such injury leads to persistent cognitive impairment associated with systemic inflammation and blood-brain barrier disruption.
DOI: 10.1016/j.bbi.2018.07.013 -
Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery—a randomized trial
This randomized trial investigates the effects of high-dose methylprednisolone on cerebrospinal fluid markers of blood-brain barrier function and neuroinflammation in patients undergoing cardiac surgery, finding that while it attenuates systemic inflammatory responses, it does n…
DOI: 10.1186/s12974-018-1318-y -
The physiological roles of ICAM-1 and ICAM-2 in neutrophil migration into tissues
This review synthesizes current evidence on how endothelial ICAM-1 and ICAM-2, pericyte ICAM-1, and epithelial ICAM-1 coordinate neutrophil trafficking from blood into inflamed tissues, detailing their redundant and distinct roles across rolling, crawling, paracellular and trans…
DOI: 10.1097/MOH.0000000000000103 -
Hypoxia augments LPS-induced inflammation and triggers high altitude cerebral edema in mice
Hypoxia augments LPS-induced inflammation and triggers high altitude cerebral edema in mice via BBB disruption, microglial activation, and AQP-4 accumulation.
DOI: 10.1016/j.bbi.2017.04.013 -
Blood-brain barrier disruption: a culprit of cognitive decline?
A comprehensive review of how blood-brain barrier disruption contributes to cognitive decline across neurological and systemic diseases, detailing BBB structure, mechanisms of disruption, links to neurodegeneration and vascular cognitive impairment, biomarkers, and therapeutic s…
DOI: 10.1186/s12987-024-00563-3 -
Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1
Human monocytes adhere to two cytokine-induced endothelial ligands, ELAM-1 and VCAM-1, via CD18 and VLA-4 pathways, demonstrated using CHO cells engineered to express these ligands and via adhesion to primary human endothelium.
DOI: 10.1182/blood.v77.10.2266.bloodjournal77102266 -
Neuregulin1-β Decreases IL-1β-Induced Neutrophil Adhesion to Human Brain Microvascular Endothelial Cells
Neuregulin-1β attenuates IL-1β–induced activation of human brain microvascular endothelial cells and reduces neutrophil adhesion, pointing to anti-inflammatory potential for neuroprotection after brain injury.
DOI: 10.1007/s12975-014-0347-9 -
Exosomes: New biomarker and therapeutic candidates in autism spectrum disorder research
A systematic review of exosome- and extracellular vesicle–based biomarker discovery and therapeutic strategies in autism spectrum disorder (ASD), highlighting cargo differences (proteins, mtDNA, RNAs) as potential biomarkers and demonstrating that mesenchymal stem cell–derived e…
DOI: 10.1017/neu.2025.10047 -
Exosomes from MSCs overexpressing microRNA-223-3p attenuate cerebral ischemia through inhibiting microglial M1 polarization mediated inflammation
Exosomes from mesenchymal stem cells engineered to overexpress miR-223-3p reduce cerebral ischemia/reperfusion injury by inhibiting microglial M1 polarization and CysLT2 receptor signaling, promoting a sustained M2 phenotype both in vivo and in vitro.
DOI: 10.1016/j.lfs.2020.118403